Lexaria Bioscience Corp. — Director's Dealing 2019

Dec 23, 2019

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Lexaria Bioscience Corp. (LXRP)
CIK: 0001348362
Period of Report: 2019-12-20

Reporting Person: Baxter Nicholas W (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2019-12-20	common shares	M	110000	$0.1	Acquired	330000	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2019-12-20	Stock Options	$0.1	M	110000	Disposed	2019-12-23	Common Shares (110000)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
common shares	220000	Direct

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Stock Options	$0.1	2019-12-23	Common Shares (110000)	110000	Direct
Stock Options	$0.99	2024-05-06	Common Shares (150000)	260000	Direct